remedium bio
Remedium Bio is a gene therapy company focused on the development of treatments for large unmet clinical needs. To enable this, we developed a revolutionary gene therapy platform technology, which enables safe, effective, and durable delivery of therapeutic genes while allowing for simple post-treatment dose adjustment. The Prometheus™ adjustable gene therapy platform is able to safely and durably replace multi-injection subcutaneously administered biologics, with a single treatment, at a fraction of the cost, and without genetic integration. Our lead product is a disease-modifying treatment for Osteoarthritis that is based on the only clinically validated chondro-regenerative mechanism. Remedium’s pipeline includes gene therapy treatments in the fields of Weight Loss, Type 2 Diabetes, and Stroke.
Modalities and Indications
REMEDIUM PIPELINE
Grounded in the Prometheus™ adjustable gene therapy platform, our pipeline consists of a broad range of regenerative therapeutics targeting diseases of aging and large clinical unmet needs. Each therapeutic candidate is developed by modularly applying proven fundamentals in novel ways, to treat well-characterized pathologies.

Get In Touch
We are always interested in starting a new conversation and are looking forward to hearing from you. Thank you in advance for your inquiry and please have a wonderful day!
1116 Great Plain Ave, Suite 203
Needham, MA
02492
E: info@remedium-bio.com
P: +1 (978) 467 5217